
Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Investment fund backing biotechnology companies developing treatments for ALS and related conditions

ALS Investment Fund holds stakes in biotechnology companies working on ALS and other neurodegenerative diseases. The material on its listing profiles several of its portfolio companies.
Developers of new therapies for diseases with limited treatment options, including Orphazyme, which targets protein-misfolding illnesses.
Summary written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about ALS Investment Fund.
Similar listings buyers compare against this one.

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Startup accelerator and early-stage investor running intensive batches for new technology founders

Venture capital firm backing pre-seed deep technology startups in health and planetary sustainability

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Impact investment group financing and supporting start-ups and small businesses across Africa

Diversified family office and investment holding company in Menlo Park with interests across technology, agribusiness and real estate
Everything here links back to the same verified catalogue. Pick your next stop.